RESUMO
Background and objectives: Alzheimer's disease (AD) is a progressive neurodegenerative disease that results in severe dementia. Having ischemic strokes (IS) is one of the risk factors of the AD, but the molecular mechanisms that underlie IS and AD are not well understood. We thus aimed to identify common molecular biomarkers and pathways in IS and AD that can help predict the progression of these diseases and provide clues to important pathological mechanisms. Materials and Methods: We have analyzed the microarray gene expression datasets of IS and AD. To obtain robust results, combinatorial statistical methods were used to analyze the datasets and 26 transcripts (22 unique genes) were identified that were abnormally expressed in both IS and AD. Results: Gene Ontology (GO) and KEGG pathway analyses indicated that these 26 common dysregulated genes identified several altered molecular pathways: Alcoholism, MAPK signaling, glycine metabolism, serine metabolism, and threonine metabolism. Further protein-protein interactions (PPI) analysis revealed pathway hub proteins PDE9A, GNAO1, DUSP16, NTRK2, PGAM2, MAG, and TXLNA. Transcriptional and post-transcriptional components were then identified, and significant transcription factors (SPIB, SMAD3, and SOX2) found. Conclusions: Protein-drug interaction analysis revealed PDE9A has interaction with drugs caffeine, γ-glutamyl glycine, and 3-isobutyl-1-methyl-7H-xanthine. Thus, we identified novel putative links between pathological processes in IS and AD at transcripts levels, and identified possible mechanistic and gene expression links between IS and AD.
Assuntos
Doença de Alzheimer/sangue , Biomarcadores/sangue , Isquemia Encefálica/sangue , 3',5'-AMP Cíclico Fosfodiesterases/análise , 3',5'-AMP Cíclico Fosfodiesterases/sangue , Doença de Alzheimer/complicações , Biomarcadores/análise , Isquemia Encefálica/complicações , Fosfatases de Especificidade Dupla/análise , Fosfatases de Especificidade Dupla/sangue , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/análise , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/sangue , Humanos , Glicoproteínas de Membrana/análise , Glicoproteínas de Membrana/sangue , Fosfatases da Proteína Quinase Ativada por Mitógeno/análise , Fosfatases da Proteína Quinase Ativada por Mitógeno/sangue , Glicoproteína Associada a Mielina/análise , Glicoproteína Associada a Mielina/sangue , Receptor trkB/análise , Receptor trkB/sangue , Transdução de Sinais/fisiologia , Acidente Vascular Cerebral/sangue , Acidente Vascular Cerebral/complicações , Proteínas de Transporte Vesicular/análise , Proteínas de Transporte Vesicular/sangueRESUMO
A rapidly progressing aging society has raised attention to white matter lesions in Alzheimer's disease. In the present study, we applied an AD plus cerebral hypoperfusion (HP) mouse model and investigated the alternation of key protein molecules in the nodal, paranodal, and intermodal sites in the white matter as well as the efficacy of galantamine. Cerebral HP was induced in APP23 mice by bilateral common carotid arteries stenosis with ameroid constrictors. Compared with the wild type and simple APP23 mice, APP23 + HP mice showed a progressive loss of MAG and NF186 from 6 to 12 months, broken misdistribution of MBP, and extended relocation of Nav1.6 and AnkG beyond the primary nodal region in the corpus callosum. Such abnormal neuropathological processes were retrieved with galantamine treatment. The present study demonstrated that cerebral HP strongly disrupted white matter integrity (WMI) at intermodal, paranodal, and Ranvier's nodal sites which may be associated with cognitive decline. Galantamine treatment significantly protected such WMI probably by allosterically potentiating ligand action.
Assuntos
Doença de Alzheimer/patologia , Isquemia Encefálica/patologia , Substância Branca/patologia , Doença de Alzheimer/metabolismo , Animais , Anquirinas/análise , Moléculas de Adesão Celular/análise , Corpo Caloso/efeitos dos fármacos , Corpo Caloso/patologia , Modelos Animais de Doenças , Galantamina/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Glicoproteína Associada a Mielina/análise , Fatores de Crescimento Neural/análise , Nootrópicos/farmacologia , Substância Branca/química , Substância Branca/efeitos dos fármacosRESUMO
White matter ischemia is difficult to quantify histologically. Myelin-associated glycoprotein (MAG) is highly susceptible to ischemia, being expressed only adaxonally, far from the oligodendrocyte cell body. Myelin-basic protein (MBP) and proteolipid protein (PLP) are expressed throughout the myelin sheath. We compared MAG, MBP, and PLP levels in parietal white matter homogenates from 17 vascular dementia (VaD), 49 Alzheimer's disease (AD), and 33 control brains, after assessing the post-mortem stability of these proteins. Small vessel disease (SVD) and cerebral amyloid angiopathy (CAA) severity had been assessed in paraffin sections. The concentration of MAG remained stable post-mortem, declined with increasing SVD, and was significantly lower in VaD than controls. The concentration of MBP fell progressively post-mortem, limiting its diagnostic utility in this context. Proteolipid protein was stable post-mortem and increased significantly with SVD severity. The MAG/PLP ratio declined significantly with SVD and CAA severity. The MAG and PLP levels and MAG/PLP did not differ significantly between AD and control brains. We validated the utility of MAG and MAG/PLP measurements on analysis of 74 frontal white matter samples from an Oxford cohort in which SVD had previously been scored. MAG concentration and the MAG/PLP ratio are useful post-mortem measures of ante-mortem white matter ischemia.
Assuntos
Doença de Alzheimer/patologia , Isquemia Encefálica/patologia , Demência Vascular/patologia , Proteína Básica da Mielina/metabolismo , Proteína Proteolipídica de Mielina/metabolismo , Glicoproteína Associada a Mielina/metabolismo , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/complicações , Doença de Alzheimer/metabolismo , Biópsia , Isquemia Encefálica/complicações , Isquemia Encefálica/metabolismo , Estudos de Coortes , Demência Vascular/complicações , Demência Vascular/metabolismo , Ensaio de Imunoadsorção Enzimática , Técnica Direta de Fluorescência para Anticorpo , Humanos , Pessoa de Meia-Idade , Proteína Básica da Mielina/análise , Proteína Proteolipídica de Mielina/análise , Glicoproteína Associada a Mielina/análise , Lobo Parietal/metabolismo , Lobo Parietal/patologia , Mudanças Depois da Morte , Estabilidade Proteica , Índice de Gravidade de DoençaRESUMO
Gangliosides are major cell-surface determinants in the central nervous system (CNS) of vertebrates, found both in neuronal and glial cell membranes. Together with cholesterol and glycosylphosphatidylinositol (GPI) - anchored proteins, gangliosides are involved in organization of plasma membrane microdomains. Based on biochemical studies, frog brain was previously described as having low quantities of gangliosides and their distribution pattern in specific brain regions was unknown. Using highly specific monoclonal antibodies generated against four major brain gangliosides (GM1, GD1a, GD1b and GT1b), we examined the distribution of these molecules in CNS of four different species of frogs (Rana esculenta, Rana temporaria, Bufo bufo and Bufo viridis). We also studied the distribution of myelin- associated glycoprotein (MAG), an inhibitor of axonal regeneration, which is a ligand for gangliosides GD1a and GT1b. Our results show that ganglioside GDla is expressed in neurons of olfactory bulb in all studied animals. In the brain of Rana sp., GD1a is expressed in the entire olfactory pathway, from olfactory bulbs to amygdala, while in Bufo sp. GD1a is restricted to the main olfactory bulb. Furthermore, we found that most of myelinated pathways in frogs express MAG, but do not express GD1a, which could be one of the reasons for better axon regeneration of neural pathways after CNS injury in amphibians in comparison to mammals.
Assuntos
Anuros , Gangliosídeos/metabolismo , Condutos Olfatórios/metabolismo , Animais , Gangliosídeos/análise , Imuno-Histoquímica , Microdomínios da Membrana , Glicoproteína Associada a Mielina/análise , Glicoproteína Associada a Mielina/metabolismo , Condutos Olfatórios/química , Especificidade de ÓrgãosRESUMO
The identification of stem cells resident in the adult central nervous system has redirected the focus of research into demyelinating diseases, such as multiple sclerosis, mainly affecting the brain white matter. This immunocytochemical and morphometrical study was carried out by confocal microscopy in the adult mouse cerebral cortex, with the aim of analysing, in the brain grey matter, the characteristics of the oligodendrocyte lineage cells, whose capability to remyelinate is still controversial. The observations demonstrated the presence in all the cortex layers of glial restricted progenitors, reactive to A2B5 marker, oligodendrocyte precursor cells, expressing the NG2 proteoglycan, and pre-oligodendrocytes and pre-myelinating oligodendrocytes, reactive to the specific marker O4. NG2 expressing cells constitute the major immature population of the cortex, since not only oligodendrocyte precursor cells and pre-oligodendrocytes but also a part of the glial restrict progenitors express the NG2 proteoglycan. Together with the population of these immature cells, a larger population of mature oligodendrocytes was revealed by the classical oligodendrocyte and myelin markers, 2',3'-cyclic nucleotide 3'-phosphodiesterase, myelin basic protein and myelin oligodendrocyte glycoprotein. The results indicate that oligodendrocyte precursors committed to differentiate into myelin forming oligodendrocytes are present through all layers of the adult cortex and that their phenotypic features exactly recall those of the oligodendroglial lineage cells during development.
Assuntos
Células-Tronco Adultas/citologia , Linhagem da Célula/fisiologia , Córtex Cerebral/citologia , Oligodendroglia/citologia , Células-Tronco/citologia , 2',3'-Nucleotídeo Cíclico Fosfodiesterases/análise , Células-Tronco Adultas/química , Animais , Antígenos/biossíntese , Antígenos/química , Astrócitos/química , Astrócitos/citologia , Biomarcadores/análise , Diferenciação Celular/fisiologia , Córtex Cerebral/química , Modelos Animais de Doenças , Encefalomielite Autoimune Experimental/metabolismo , Encefalomielite Autoimune Experimental/patologia , Camundongos , Camundongos Endogâmicos C57BL , Microscopia Confocal/métodos , Microscopia Confocal/tendências , Proteína Básica da Mielina/análise , Proteínas da Mielina , Glicoproteína Associada a Mielina/análise , Glicoproteína Mielina-Oligodendrócito , Oligodendroglia/química , Proteoglicanas/biossíntese , Proteoglicanas/química , Células-Tronco/químicaRESUMO
Global proteomic analysis of post-mortem anterior temporal lobe samples from schizophrenia patients and non-schizophrenia individuals was performed using stable isotope labeling and shotgun proteomics. Our analysis resulted in the identification of 479 proteins, 37 of which showed statistically significant differential expression. Pathways affected by differential protein expression include transport, signal transduction, energy pathways, cell growth and maintenance and protein metabolism. The collection of protein alterations identified here reinforces the importance of myelin/oligodendrocyte and calcium homeostasis in schizophrenia, and reveals a number of new potential markers that may contribute to the understanding of the pathogenesis of this complex disease.
Assuntos
Cálcio/metabolismo , Glicoproteína Associada a Mielina/análise , Proteínas do Tecido Nervoso/análise , Proteoma/química , Esquizofrenia/metabolismo , Lobo Temporal/química , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/análise , Proliferação de Células , Cromatografia Líquida de Alta Pressão , Metabolismo Energético , Feminino , Humanos , Masculino , Espectrometria de Massas/métodos , Pessoa de Meia-Idade , Proteínas da Mielina , Glicoproteína Mielina-Oligodendrócito , Mudanças Depois da Morte , Transporte Proteico , Proteômica/métodos , Valores de Referência , Transdução de SinaisRESUMO
The central nervous system myelin sheath is a multilayered specialized membrane with compacted and non-compacted domains of defined protein composition. How oligodendrocytes regulate myelin membrane trafficking and establish membrane domains during myelination is largely unknown. Oligodendroglial cells respond to neuronal signals by adjusting the relative levels of endocytosis and exocytosis of the major myelin protein, proteolipid protein (PLP). We investigated whether endocytic trafficking is common to myelin proteins and analyzed the endocytic fates of proteins with distinct myelin subdomain localization. Interestingly, we found that PLP, myelin-associated glycoprotein (MAG) and myelin-oligodendrocyte glycoprotein (MOG), which localize to compact myelin, periaxonal loops and abaxonal loops, respectively, exhibit distinct endocytic fates. PLP was internalized via clathrin-independent endocytosis, whereas MAG was endocytosed by a clathrin-dependent pathway, although both proteins were targeted to the late-endosomal/lysosomal compartment. MOG was also endocytosed by a clathrin-dependent pathway, but in contrast to MAG, trafficked to the recycling endosome. Endocytic recycling resulted in the association of PLP, MAG and MOG with oligodendroglial membrane domains mimicking the biochemical characteristics of myelin domains. Our results suggest that endocytic sorting and recycling of myelin proteins may assist plasma membrane remodeling, which is necessary for the morphogenesis of myelin subdomains.
Assuntos
Membrana Celular/metabolismo , Endocitose , Proteínas da Mielina/metabolismo , Oligodendroglia/metabolismo , Animais , Membrana Celular/química , Camundongos , Proteína Proteolipídica de Mielina/análise , Proteína Proteolipídica de Mielina/metabolismo , Glicoproteína Associada a Mielina/análise , Glicoproteína Associada a Mielina/metabolismo , Glicoproteína Mielina-OligodendrócitoRESUMO
OBJECTIVE: Four different patterns of demyelination have been described in active demyelinating lesions of multiple sclerosis (MS) patients that were biopsied shortly after disease onset. These patterns were suggested to represent heterogeneity of the underlying pathogenesis. The aim of this study was to determine whether lesion heterogeneity also exists in an unselected collection of autopsy material from patients with established MS. METHODS: All MS brain tissue available in the VU Medical Center was assessed for the presence of active demyelinating lesions using magnetic resonance imaging-guided sampling and immunohistochemistry. Tissue blocks containing active demyelinating lesions were evaluated for the presence of complement and antibody deposition, oligodendrocyte apoptosis, differential loss of myelin proteins, and hypoxia-like damage using histology, immunohistochemistry, and confocal microscopy. Blocks with active demyelinating lesions were compared with blocks with active (nondemyelinating) and inactive lesions. RESULTS: Complement and antibodies were consistently associated with macrophages in areas of active demyelination. Preferential loss of myelin proteins, extensive hypoxia-like damage, and oligodendrocyte apoptosis were absent or rare. This pattern was observed in all tissue blocks containing active demyelinating lesions; lesion heterogeneity between patients was not found. INTERPRETATION: The immunopathological appearance of active demyelinating lesions in established MS is uniform. Initial heterogeneity of demyelinating lesions in the earliest phase of MS lesion formation may disappear over time as different pathways converge in one general mechanism of demyelination. Consistent presence of complement, antibodies, and Fcgamma receptors in phagocytic macrophages suggests that antibody- and complement-mediated myelin phagocytosis is the dominant mechanism of demyelination in established MS.
Assuntos
Sistema Nervoso Central/patologia , Esclerose Múltipla/patologia , Fibras Nervosas Mielinizadas/patologia , Adulto , Idoso , Apoptose/imunologia , Autoanticorpos/análise , Autoanticorpos/imunologia , Autoantígenos/imunologia , Autoimunidade/imunologia , Autopsia , Biomarcadores/análise , Biomarcadores/metabolismo , Sistema Nervoso Central/imunologia , Sistema Nervoso Central/metabolismo , Ativação do Complemento/imunologia , Proteínas do Sistema Complemento/análise , Proteínas do Sistema Complemento/imunologia , Progressão da Doença , Feminino , Humanos , Imunoglobulina G/análise , Imunoglobulina G/imunologia , Macrófagos/imunologia , Macrófagos/patologia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/imunologia , Esclerose Múltipla/metabolismo , Glicoproteína Associada a Mielina/análise , Glicoproteína Associada a Mielina/imunologia , Oligodendroglia/imunologia , Oligodendroglia/patologiaRESUMO
Nodes of Ranvier are regularly placed, nonmyelinated axon segments along myelinated nerves. Here we show that nodal membranes isolated from the central nervous system (CNS) of mammals restricted neurite outgrowth of cultured neurons. Proteomic analysis of these membranes revealed several inhibitors of neurite outgrowth, including the oligodendrocyte myelin glycoprotein (OMgp). In rat spinal cord, OMgp was not localized to compact myelin, as previously thought, but to oligodendroglia-like cells, whose processes converge to form a ring that completely encircles the nodes. In OMgp-null mice, CNS nodes were abnormally wide and collateral sprouting was observed. Nodal ensheathment in the CNS may stabilize the node and prevent axonal sprouting.
Assuntos
Axônios/fisiologia , Extensões da Superfície Celular/fisiologia , Neuritos/fisiologia , Neuroglia/fisiologia , Neuroglia/ultraestrutura , Nós Neurofibrosos/fisiologia , Animais , Antígenos/análise , Axônios/ultraestrutura , Bovinos , Extensões da Superfície Celular/química , Extensões da Superfície Celular/ultraestrutura , Células Cultivadas , Proteínas Ligadas por GPI , Gânglios Espinais/fisiologia , Gânglios Espinais/ultraestrutura , Humanos , Camundongos , Proteínas da Mielina , Bainha de Mielina/química , Glicoproteína Associada a Mielina/análise , Glicoproteína Mielina-Oligodendrócito , Neuritos/ultraestrutura , Neuroglia/química , Oligodendroglia/química , Oligodendroglia/fisiologia , Oligodendroglia/ultraestrutura , Proteoglicanas/análise , Proteômica , Nós Neurofibrosos/química , Nós Neurofibrosos/ultraestrutura , Ratos , Medula Espinal/citologiaRESUMO
Mice exposed to various stresses, especially restrained-stress, revealed the anxiogenic effect detected by the light-dark test. Under this condition, a remarkable decrease in [35S]GTPgammaS binding to membranes from the prefrontal cortex, amygdala and hypothalamus of restrained-stress mice stimulated by the selective 5-HT1A receptor agonist 5-carboxamidotriptamine (5-CT) was clearly observed, whereas a significant increase in [35S]GTPgammaS binding stimulated by the 5-HT1A receptor agonist was clearly observed in the dorsal raphe nuclei (DRN) of restrained-stress mice. The immunohistochemical study showed a drastic reduction in phosphorylated-CREB-like immunoreactivity in the DRN of restrained-stress mice. Furthermore, we found a drastic reduction in myelin-associated glycoprotein (MAG)-like immunoreactivity (MAG-IR) in the DRN, amygdala and hypothalamus, indicating the direct suppression of synaptic transmission in these regions. It has been accepted that GSK3beta in the Wnt signal pathway plays an important role in various neuronal functions including apoptosis, clustering of synapsin I and early growth and axonal remodeling. In the present study, the increase in protein levels of GSK3beta and phosphorylated-GSK3beta to cytosol fractions of the amygdala was noted in restrained-stress mice. Taken together, these results suggest that restrained stress may directly affect the 5-HT1A receptor-regulated synaptic transmission in the brain, leading to the expression of the anxiogenic effect in mice. It is well known that various stresses induce intracellular oxidative stress. The present study was then undertaken to investigate the effect of the stimulation of 5-HT1A receptors on oxidative stress. Treatment with H2O2 caused the activation of caspase-3-positive cells and the reduction in levels of MAG-IR in the limbic neuron/glia cocultures as compared to medium alone. The stimulation of 5-HT1A receptor by 5-CT produced a dramatic protection against H2O2-triggered activation of caspase-3 and reduction in levels of MAG-IR. These results suggest that 5-HT1A receptors were involved in the modulation of anxiety and the understanding of molecular mechanisms of 5-HT1A receptor-related cascades may pave the way for new therapeutic strategies for affective disorders.
Assuntos
Receptor 5-HT1A de Serotonina/fisiologia , Estresse Psicológico/fisiopatologia , Tonsila do Cerebelo/química , Animais , Ansiedade/metabolismo , Western Blotting , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/análise , Feminino , Proteína GAP-43/análise , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Hipotálamo/química , Imuno-Histoquímica , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos ICR , Glicoproteína Associada a Mielina/análise , Córtex Pré-Frontal/química , Serotonina/análogos & derivados , Serotonina/farmacologiaRESUMO
Schwann cells within a peripheral nerve respond robustly after an axonal injury. Recent results have revealed that Schwann cells undergo concurrent proliferation and apoptosis after a chronic nerve injury that is independent of axonal pathology. Although the exact nature of the stimulus that produces this Schwann cell response remains unknown, we postulated that this response may be triggered directly by mechanical stimuli. Thus, we sought to determine how pure Schwann cells responded to a sustained shear stress in the form of laminar fluid flow by evaluating for proliferation, expression of S-100, myelin-associated glycoprotein (MAG), and myelin basic protein (MBP). Immunohistochemistry demonstrated that the Schwann cells were positive for S-100, MAG, and MBP in greater than 99% of the experimental cells. Stimulated cells also revealed an increased rate of proliferation by as much as 100% (p<.001). The mRNA expression of MAG and MBP was down-regulated by 21% (p<.035) and 18% (p<.015), respectively, in experimental cells from RT-PCR assays. Furthermore, Western blot showed a down-regulation in MAG and MBP protein expression by 29% (p<.035) and 35% (p<.02), respectively. This study provides novel information regarding Schwann cell direct response to this physical stimulus that is not secondary to an axonal injury.
Assuntos
Regulação da Expressão Gênica , Proteína Básica da Mielina/genética , Glicoproteína Associada a Mielina/genética , Células de Schwann/metabolismo , Animais , Western Blotting , Proliferação de Células , Células Cultivadas , Imuno-Histoquímica , Proteína Básica da Mielina/análise , Glicoproteína Associada a Mielina/análise , Ratos , Ratos Sprague-Dawley , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células de Schwann/química , Células de Schwann/citologia , Estresse MecânicoRESUMO
Using adult male C57BL/6 mice that express a yellow fluorescent protein transgene in their motor neurons, we induced experimental autoimmune encephalomyelitis (EAE) by immunization with myelin oligodendrocyte glycoprotein peptide 35-55 (MOG peptide) in complete Freund's adjuvant (CFA). Control mice of the same transgenic strain received CFA without MOG peptide. Early in the course of their illness, the EAE mice showed lumbosacral spinal cord inflammation, demyelination and axonal fragmentation. By 14 weeks post-MOG peptide, these abnormalities were much less prominent, but the mice remained weak and, as in patients with progressive multiple sclerosis, spinal cord atrophy had developed. There was no significant loss of lumbar spinal cord motor neurons in the MOG peptide-EAE mice. However, early in the course of the illness, motor neuron dendrites were disrupted and motor neuron expression of hypophosphorylated neurofilament-H (hypoP-NF-H) immunoreactivity was diminished. By 14 weeks post-MOG peptide, hypoP-NF-H expression had returned to normal, but motor neuron dendritic abnormalities persisted and motor neuron perikaryal atrophy had appeared. We hypothesize that these motor neuron abnormalities contribute to weakness in this form of EAE and speculate that similar motor neuron abnormalities are present in patients with progressive multiple sclerosis.
Assuntos
Encefalomielite Autoimune Experimental/patologia , Neurônios Motores/patologia , Animais , Atrofia , Axônios/patologia , Doenças Autoimunes Desmielinizantes do Sistema Nervoso Central/patologia , Dendritos/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Proteínas da Mielina , Glicoproteína Associada a Mielina/análise , Glicoproteína Mielina-Oligodendrócito , Proteínas de Neurofilamentos/análise , Fenótipo , Fosforilação , Medula Espinal/patologiaRESUMO
The developing CNS, and in particular the visual system, is very sensitive to the effects of alcohol. Alcohol causes lipid peroxidation. Squalene, the major olive oil hydrocarbon, is a quencher of singlet oxygen and prevents the corresponding lipid peroxidation. We presumed that squalene can protect against the alcohol-induced damage already observed during the development of the chick retina. Alcohol+squalene was administered directly into the yolk sac of the egg of White Leghorn chicks at day 6 of incubation. The lipid composition of the retina was analyzed in embryos at E7, E11, E15 and E18. The proportions of phospholipids, free and esterified cholesterol, diacylglycerides and free fatty acids were estimated using the Iatroscan TLC/FID procedure. Gas chromatography and mass spectrometry were used to determine the fatty acid composition. The morphological study was carried out at E11 using semithin sections, and by means of immunohistochemical techniques at E19. Comparing the results obtained in control embryos, the administration of alcohol+squalene reduces the effects of alcohol on the total lipid composition of the retina during development. The effects were, in fact, of less magnitude than in embryos treated only with alcohol. The major phospholipid species of alcohol+squalene-treated embryos exhibited total recuperation at E15. As far as fatty acids are concerned, no significant changes were observed with regard to control embryos during development. From a morphological point of view, the retinas of alcohol+squalene-treated embryos show at E11 fewer cellular alterations than the retinas of alcohol-treated embryos. In this respect, the retinas of alcohol+squalene-treated embryos exhibited: a columnar cell arrangement similar to that observed in control retinas; few pycnotic cells and very few alterations in ganglion cell layers and in the optic nerve fibers layer. At E19 the recuperation of the expression of myelin oligodendrocyte specific protein (MOSP) in alcohol+squalene-treated embryos was recorded. Since squalene reduces the deleterious effects caused by alcohol on the lipid composition and the structure of the retina, squalene could act as a naturally occurring agent for the prevention of damage caused by abusive alcohol ingestion during pregnancy.
Assuntos
Depressores do Sistema Nervoso Central/farmacologia , Etanol/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Retina/efeitos dos fármacos , Esqualeno/farmacologia , Animais , Embrião de Galinha , Colesterol/análise , Diglicerídeos/análise , Ácidos Graxos/análise , Imuno-Histoquímica/métodos , Proteínas da Mielina , Glicoproteína Associada a Mielina/análise , Glicoproteína Mielina-Oligodendrócito , Fosfolipídeos/análise , Retina/embriologia , Retina/patologiaRESUMO
There is considerable evidence that multiple sclerosis (MS) is an immune-mediated disease characterized by infiltration of inflammatory cells into the CNS and demyelination. Several myelin proteins may be encephalitogenic, including myelin basic protein, proteolipid protein and myelin oligodendrocyte glycoprotein (MOG), the latter being expressed on the external layer of myelin sheaths and hence accessible to antibody attack. We investigated MOG autoreactivity in serum and cerebrospinal fluid (CSF) by ELISA, employing the recombinant extracellular domain of MOG as antigen. We tested serum samples from 262 MS patients (175 relapsing-remitting, 43 primary progressive and 44 secondary progressive), 131 patients with other neurological diseases (OND) and 307 healthy controls. No patients or controls were receiving immunomodulating treatments. We found anti-MOG antibodies in the serum of 13.7% MS patients, mainly in those with secondary progressive MS (25%), in 13.7% of OND patients and in 6.2% of controls. We found a direct correlation (R(2) = 0.6, P = 0.002) between disease severity and anti-MOG titer only in patients with primary and secondary progressive MS. Anti-MOG antibodies were present in the CSF of 11.4% MS patients and 18.9% OND patients. Intrathecal synthesis of anti-MOG antibodies was demonstrated in four (4.5%) of MS patients and no OND patients. Anti-MOG antibodies are not specific for MS; however, they may characterize a subset of MS patients and this may be revealed by serial assays in relation to changing disease phase.
Assuntos
Autoanticorpos/sangue , Esclerose Múltipla/imunologia , Glicoproteína Associada a Mielina/imunologia , Adulto , Análise de Variância , Autoanticorpos/líquido cefalorraquidiano , Doenças Autoimunes do Sistema Nervoso/sangue , Doenças Autoimunes do Sistema Nervoso/líquido cefalorraquidiano , Doenças Autoimunes do Sistema Nervoso/imunologia , Western Blotting , Doenças do Sistema Nervoso Central/sangue , Doenças do Sistema Nervoso Central/líquido cefalorraquidiano , Doenças do Sistema Nervoso Central/imunologia , Avaliação da Deficiência , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunoglobulina G/sangue , Imunoglobulina G/líquido cefalorraquidiano , Itália , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/sangue , Esclerose Múltipla/diagnóstico , Esclerose Múltipla Crônica Progressiva/sangue , Esclerose Múltipla Crônica Progressiva/líquido cefalorraquidiano , Esclerose Múltipla Crônica Progressiva/imunologia , Esclerose Múltipla Recidivante-Remitente/sangue , Esclerose Múltipla Recidivante-Remitente/líquido cefalorraquidiano , Esclerose Múltipla Recidivante-Remitente/imunologia , Proteínas da Mielina , Glicoproteína Associada a Mielina/análise , Glicoproteína Associada a Mielina/genética , Glicoproteína Mielina-Oligodendrócito , Bandas Oligoclonais/análise , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/imunologia , Sensibilidade e Especificidade , Coluna Vertebral/química , Coluna Vertebral/imunologia , Coluna Vertebral/metabolismoRESUMO
Schizophrenia unfolds during the late period of brain maturation, while myelination is still continuing. In the present study, we used MRI and T2 relaxation analysis to measure the myelin water fraction in schizophrenia. In schizophrenia (n=30) compared with healthy subjects (n=27), overall white matter showed 12% lower myelin water fraction (P=0.031), with the most prominent effects on the left genu of the corpus callosum (36% lower, P=0.002). The left anterior genu was affected in both first-episode (P=0.035) and chronic patients (P=0.011). In healthy subjects, myelin water fraction in total white matter and in frontal white matter increased with age, and with years of education, indicating ongoing maturation. In patients with schizophrenia, neither relation was statistically significant. Post-mortem studies of anterior frontal cortex demonstrated less immunoreactivity of two oligodendrocyte-associated proteins in schizophrenia (2',3'-cyclic nucleotide 3'-phosphodiesterase by 33%, P=0.05; myelin-associated glycoprotein by 27%, P=0.14). Impaired myelination in schizophrenia could contribute to abnormalities of neural connectivity and persistent functional impairment in the illness.
Assuntos
Doenças Desmielinizantes/diagnóstico , Fibras Nervosas Mielinizadas/patologia , Esquizofrenia/patologia , 2',3'-Nucleotídeo Cíclico Fosfodiesterases/análise , Adulto , Composição Corporal/fisiologia , Compartimentos de Líquidos Corporais/fisiologia , Doença Crônica , Doenças Desmielinizantes/complicações , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Análise por Pareamento , Pessoa de Meia-Idade , Bainha de Mielina/química , Glicoproteína Associada a Mielina/análise , Oligodendroglia/química , Oligodendroglia/patologia , Valores de Referência , Esquizofrenia/complicações , Água/análiseRESUMO
The design of nerve guidance channels (NGCs) is evolving to produce a favorable environment for neural regeneration. We created an in vitro model to evaluate the interactions between three centrally important components of this altered host environment: (1). Schwann cells, (2). substrate, and (3). sustained mechanical stimulus in the form of shear stress with laminar fluid flow. Preconfluent Schwann cells were plated on slides coated either with laminin, poly-D-lysine, type IV collagen, or fibronectin. These slides were placed into custom-designed, parallel-plate, flow chambers and were administered laminar fluid flow at a rate of 15 mL/min for 2 h. Schwann cell adhesion assays demonstrated that laminin (mean, 86.1%; SEM, 4.47%) and fibronectin (mean, 81.7%; SEM, 3.24%) were statistically superior to collagen type IV (mean, 57.7%; SEM, 3.96%) and poly-D-lysine (mean, 58.0%; SEM, 4.97%) (p < 0.001). Fibronectin (mean, 12.20%; SEM, 0.374%) induced statistically greater Schwann cell proliferation than did laminin (mean, 8.14%; SEM, 0.682%) (p < 0.001). Therefore, we recommend that fibronectin should be used as an important component of NGCs with further in vivo studies. As mechanical stress is an integral part of the host environment, our study is the first to incorporate this factor into an in vitro model for peripheral nerve tissue engineering.
Assuntos
Adesão Celular , Regeneração Nervosa , Células de Schwann/citologia , Estresse Mecânico , Engenharia Tecidual/métodos , Animais , Biomarcadores , Adesão Celular/efeitos dos fármacos , Divisão Celular , Colágeno Tipo IV/farmacologia , Fibronectinas/farmacologia , Laminina/farmacologia , Proteína Básica da Mielina/análise , Glicoproteína Associada a Mielina/análise , Proteínas do Tecido Nervoso/análise , Polilisina/farmacologia , Ratos , Ratos Sprague-Dawley , Reologia , Proteínas S100/análise , Células de Schwann/química , Células de Schwann/efeitos dos fármacos , Nervo Isquiático/citologia , Engenharia Tecidual/instrumentaçãoRESUMO
Since 1979, the authors have studied 49 peripheral nerve biopsies presenting uncompacted myelin lamellae (UML). Based on the ultrastructural pattern of UML they propose a 3-category classification. The first category includes cases displaying regular UML, which was observed in 43 cases; it was more frequent in 9 cases with polyneuropathy organomegaly endocrinopathy m-protein skin changes (POEMS) syndrome as well as in 1 case of Charcot-Marie-Tooth 1B with a novel point mutation in the P0 gene. The second category consists of cases showing irregular UML, observed in 4 cases with IgM monoclonal gammopathy and anti-myelin-associated glycoprotein (MAG) activity. This group included 1 benign case and 3 B-cell malignant lymphomas. The third category is complex UML, which was present in 2 unrelated patients with an Arg 98 His missense mutation in the P0 protein gene. Irregular and complex UML are respectively related to MAG and P0, which play a crucial role in myelin lamellae compaction and adhesion.
Assuntos
Bainha de Mielina/ultraestrutura , Nervos Periféricos/ultraestrutura , Doenças do Sistema Nervoso Periférico/patologia , Arginina/genética , Biópsia , Doença de Charcot-Marie-Tooth/genética , Doença de Charcot-Marie-Tooth/patologia , Histidina/genética , Humanos , Linfoma de Células B/patologia , Microscopia Eletrônica , Mutação , Proteína P0 da Mielina/genética , Bainha de Mielina/classificação , Glicoproteína Associada a Mielina/análise , Síndrome POEMS/patologia , Paraproteinemias/patologia , Doenças do Sistema Nervoso Periférico/genéticaRESUMO
Destruction of myelin and oligodendrocytes leading to the formation of large demyelinated plaques is the hallmark of multiple sclerosis (MS) pathology. In a subset of MS patients termed pattern III, actively demyelinating lesions show preferential loss of myelin-associated glycoprotein (MAG) and apoptotic-like oligodendrocyte destruction, whereas other myelin proteins remain well preserved. MAG is located in the most distal periaxonal oligodendrocyte processes and primary "dying back" oligodendrogliopathy may be the initial step of myelin degeneration in pattern III lesions. In the present study, various human white matter pathologies, including acute and chronic white matter stroke, virus encephalitis, metabolic encephalopathy, and MS were studied. In addition to a subset of MS cases, a similar pattern of demyelination was found in some cases of virus encephalitis as well as in all lesions of acute white matter stroke. Brain white matter lesions presenting with MAG loss and apoptotic-like oligodendrocyte destruction, irrespective of their primary disease cause, revealed a prominent nuclear expression of hypoxia inducible factor-1alpha in various cell types, including oligodendrocytes. Our data suggest that a hypoxia-like tissue injury may play a pathogenetic role in a subset of inflammatory demyelinating brain lesions.
Assuntos
Encefalite/metabolismo , Hipóxia-Isquemia Encefálica/metabolismo , Glicoproteína Associada a Mielina/metabolismo , Oligodendroglia/metabolismo , Acidente Vascular Cerebral/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Encefalopatias/metabolismo , Encefalopatias/patologia , Criança , Encefalite/patologia , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia , Hipóxia-Isquemia Encefálica/patologia , Pessoa de Meia-Idade , Glicoproteína Associada a Mielina/análise , Oligodendroglia/química , Oligodendroglia/patologia , Acidente Vascular Cerebral/patologia , Fatores de Transcrição/biossínteseRESUMO
To further our understanding of the functions of the major myelin proteins, myelin basic protein (MBP) and proteolipid protein (PLP), and other myelin proteins, such as 2'3'-cyclic nucleotide 3'-phosphodiesterase (CNP) and myelin-associated glycoprotein (MAG), bovine brain myelin was extracted with Triton X-100, and protein complexes in the detergent-soluble fraction were isolated by coimmunoprecipitation and sucrose density gradient sedimentation. MBP, PLP, and the small isoform of MAG (S-MAG) were coimmunoprecipitated from the detergent-soluble fraction by anti-PLP, anti-MBP or anti-MAG monoclonal antibodies. Additionally, a 30 kDa phosphoserine-containing protein and two phosphotyrosine-containing proteins (M(r) 30 and 42 kDa) were found in the coimmunoprecipitates. The 42 kDa protein is probably p42MAPK, in that MAPK was shown also to be present in the immunoprecipitated complex. CNP, the small PLP isoform DM20, the large MAG isoform L-MAG, MOG, CD44, MEK, p44MAPK, and actin were not present in the immunoprecipitates, although they were present in the detergent-soluble fraction. Lipid analysis revealed that the PLP-MBP-S-MAG coimmunoprecipitated with some phospholipids and sulfatide but not cholesterol or galactosylceramide. However, the complex had a high density, indicating that the lipid/protein ratio is low, and it was retained on a Sepharose CL6B column, indicating that it is not a large membrane fragment. Given that MAG is localized mainly in the periaxonal region of myelin, where it interacts with axonal ligands, the PLP-MBP-S-MAG complex may come from these regions, where it could participate in dynamic functions in the myelin sheath and myelin-axonal interactions.
Assuntos
Sistema Nervoso Central/química , Proteína Quinase 1 Ativada por Mitógeno/análise , Proteína Básica da Mielina/análise , Proteína Proteolipídica de Mielina/análise , Animais , Western Blotting , Bovinos , Extratos Celulares/química , Centrifugação com Gradiente de Concentração/métodos , Cromatografia em Gel/métodos , Immunoblotting , Glicoproteína Associada a Mielina/análise , Octoxinol , Fosfosserina/análise , Fosfotirosina/análise , Testes de Precipitina/métodos , SolubilidadeRESUMO
Dystonia musculorum (dt) is an autosomal recessive sensory neuropathy in mice resulting from a mutation in the gene encoding the cytoskeletal linker protein Bpag1. In addition to neurodegeneration, dt mice display myelination abnormalities in the peripheral nervous system. In this report we investigated whether myelination abnormalities are also present in the central nervous system of dt(Tg4) mice. Transcripts for both neural isoforms of Bpag1 (a1 and a2) were detected in optic nerves and spinal cords of wild-type mice. Light microscopy of resin-embedded thin sections revealed a reduction in myelinated axons in both optic nerves and spinal cords in dt(Tg4) mice. As well, hypermyelinated axons were detected in these tissues. Ultrastructural analysis of optic nerves and spinal cords from dt(Tg4) mice revealed an increase in the number of amyelinated axons, the presence of hypo- and hypermyelinated axons, and redundant myelin that course away from axons. Changes in the level of myelin proteins accompanied the morphological alterations. Myelin-associated glycoprotein levels were reduced in optic nerves of dt(Tg4) mice, and myelin basic protein levels were altered in optic nerves, sciatic nerves, and spinal cords of affected mice. Short-term cultures of oligodendrocytes derived from dt(Tg4) mice did not show morphological alterations.